(Q36718164)

15 August 2017

Ursodeoxycholic acid therapy in chronic active hepatitis (English)

1 reference

15 August 2017

Bateson MC

1

1 reference

PMC publication ID

2426868

15 August 2017

language of work or name

English

0 references

publication date

1 September 1990

1 reference

Postgraduate Medical Journal

15 August 2017

1 reference

15 August 2017

66

1 reference

15 August 2017

779

1 reference

15 August 2017

781-783

1 reference

Bile acids, liver injury, and liver disease

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426868

Autoimmune chronic active hepatitis: three decades of progress

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426868

Ursodeoxycholic acid for chronic liver diseases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426868

Norethisterone jaundice in two sisters.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426868

Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426868

Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426868

Cyclosporine treatment of autoimmune chronic active hepatitis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426868

Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

28 June 2018

1 reference

12 December 2020

Treatment of primary biliary cirrhosis and cholestatic disorders with ursodeoxycholic acid

1 reference

12 December 2020

Bile acid metabolism in cirrhotic liver tissue--altered synthesis and impaired hepatic secretion

1 reference

12 December 2020

Deterioration of primary biliary cirrhosis during treatment with ursodeoxycholic acid

1 reference

12 December 2020

Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis

1 reference

12 December 2020

Ursodeoxycholic acid in primary biliary cirrhosis

1 reference

12 December 2020

Effect of chenodeoxycholic and ursodeoxycholic acids on isolated adult human hepatocytes

1 reference

12 December 2020

Identifiers

DOI

10.1136/PGMJ.66.779.781

1 reference

15 August 2017

1 reference

PMC publication ID

2426868

15 August 2017

PubMed publication ID

2235818

1 reference

PMC publication ID

2426868